+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
mRNA Therapeutics Market by Technology Platform (Lipid Nanoparticles, Polymer Based, Viral Vectors), Therapeutic Application (Cardiovascular, Infectious Diseases, Oncology), Delivery Method - Global Forecast 2025-2030- Product Image
mRNA Therapeutics Market by Technology Platform (Lipid Nanoparticles, Polymer Based, Viral Vectors), Therapeutic Application (Cardiovascular, Infectious Diseases, Oncology), Delivery Method - Global Forecast 2025-2030- Product Image
Sale

mRNA Therapeutics Market by Technology Platform (Lipid Nanoparticles, Polymer Based, Viral Vectors), Therapeutic Application (Cardiovascular, Infectious Diseases, Oncology), Delivery Method - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666329
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The mRNA therapeutics market is rapidly transforming global healthcare by enabling new preventive and curative options across a diverse range of conditions. With accelerated innovation, evolving regulatory frameworks, and increased investment, senior decision-makers face unique opportunities and challenges as the sector redefines standards in treatment development and commercialization.

Market Snapshot: mRNA Therapeutics Market Size and Growth Trajectory

The mRNA therapeutics market grew from USD 41.99 billion in 2024 to USD 52.59 billion in 2025. It is expected to continue growing at a CAGR of 24.78%, reaching USD 158.60 billion by 2030. This robust expansion signals substantial momentum driven by advances in delivery systems, expanding therapeutic pipelines, and accelerating adoption curves in both established and emerging markets. Industry stakeholders are actively recalibrating strategies to adapt to this unprecedented pace of change and capitalize on expanding commercial opportunities.

Scope & Segmentation of the mRNA Therapeutics Market

This report provides in-depth analysis of the market’s primary segments, empowering informed decisions:

  • Technology Platforms: Lipid nanoparticles dominate as the preferred vehicle for mRNA delivery. Polymer-based systems are drawing attention for biocompatibility and controlled release, while viral vectors leverage gene therapy experience for long-term expression needs.
  • Therapeutic Applications: Cardiovascular, infectious diseases, oncology, and rare diseases are the leading areas of development, reflecting broadening scope and pipeline diversification beyond vaccines.
  • Delivery Methods: Approaches include intramuscular administration for vaccines, intravenous infusion for systemic protein expression, and subcutaneous injections targeting improved patient compliance and chronic care needs.
  • Regional Coverage: Americas (with emphasis on the United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including the United Kingdom, Germany, France, key Middle Eastern and African economies), and Asia-Pacific (China, India, Japan, Australia, South Korea, and other active participants).
  • Key Industry Players: Major organizations reviewed in this analysis include Moderna, BioNTech, CureVac, Sanofi, Pfizer, GlaxoSmithKline, Arcturus Therapeutics, Providence Therapeutics, Ethris, and eTheRNA immunotherapies.

Key Takeaways for Senior Decision-Makers

  • mRNA therapeutics are reshaping disease management paradigms by harnessing the body’s translational machinery, opening new avenues in precision medicine.
  • Regulatory agencies are streamlining approval pathways for mRNA-based therapies, supporting faster timelines for investigational drugs and licensing activities.
  • Enhanced delivery systems, such as optimized lipid nanoparticles, are driving clinical success and fueling expanded R&D investment across the biotech and pharmaceutical sectors.
  • Strategic collaborations and partnerships between innovators, manufacturers, and research consortia are accelerating technology transfer and scaling capabilities along the global supply chain.
  • Pipelines are diversifying from infectious disease vaccines to include indications like oncology, rare genetic disorders, and cardiovascular conditions, underlining the modularity and flexibility of the platform.

Tariff Impact: Implications of United States Trade Policies

The introduction of new United States tariffs in 2025 presents operational complexities throughout mRNA therapeutics supply chains. Key stakeholders face increased input costs, which may prompt supply agreement renegotiation and vendor diversification. Companies with in-house capabilities gain insulation from price volatility, while smaller innovators may seek consortium models or alternative funding to contain tariff-driven overhead. Regulatory bodies and trade organizations are preparing position papers to advocate for exemptions specific to biologics inputs, and supply chain diversification emerges as a core risk mitigation strategy.

Methodology & Data Sources

This research leverages a comprehensive multi-source methodology. Inputs include peer-reviewed publications, patent landscape analyses, executive interviews, clinical trial and regulatory registry reviews, and professional conference materials. Data validation protocols are employed throughout to ensure accuracy and reliability.

Why This Report Matters

  • Provides executive-level visibility into evolving market dynamics, regulatory trends, and platform advancements in mRNA therapeutics.
  • Delivers actionable strategic guidance to help optimize investment, partnership, and commercialization decisions across a dynamic competitive landscape.

Conclusion

This report equips industry leaders with nuanced perspectives and practical recommendations for navigating the evolving mRNA therapeutics ecosystem. By leveraging these insights, stakeholders can position their organizations for sustained success and future growth.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Engineering novel lipid nanoparticle vectors to enhance tissue-specific mRNA delivery
5.2. Integration of self-amplifying mRNA platforms to lower dosing frequency and costs
5.3. Regulatory pathways evolving for accelerated approval of mRNA-based cancer vaccines
5.4. Collaborations between biotech firms and academia to develop personalized mRNA therapeutics for rare diseases
5.5. Development of hybrid DNA/mRNA constructs to improve stability and translation efficiency in vivo
5.6. Exploration of novel adjuvants to potentiate immune response in prophylactic mRNA immunotherapies
5.7. Scale-up of continuous manufacturing processes for cost-effective large-scale mRNA production
5.8. Addressing cold chain logistics by innovating lyophilization techniques for mRNA vaccine distribution
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. mRNA Therapeutics Market, by Technology Platform
8.1. Introduction
8.2. Lipid Nanoparticles
8.3. Polymer Based
8.4. Viral Vectors
9. mRNA Therapeutics Market, by Therapeutic Application
9.1. Introduction
9.2. Cardiovascular
9.3. Infectious Diseases
9.4. Oncology
9.5. Rare Diseases
10. mRNA Therapeutics Market, by Delivery Method
10.1. Introduction
10.2. Intramuscular
10.3. Intravenous
10.4. Subcutaneous
11. Americas mRNA Therapeutics Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa mRNA Therapeutics Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific mRNA Therapeutics Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Moderna, Inc.
14.3.2. BioNTech SE
14.3.3. CureVac N.V.
14.3.4. Sanofi S.A.
14.3.5. Pfizer Inc.
14.3.6. GlaxoSmithKline plc
14.3.7. Arcturus Therapeutics Holdings, Inc.
14.3.8. Providence Therapeutics Holdings Inc.
14.3.9. Ethris GmbH
14.3.10. eTheRNA immunotherapies NV
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. MRNA THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL MRNA THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2030 (%)
FIGURE 6. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2030 (%)
FIGURE 10. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 12. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 14. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 20. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 21. MRNA THERAPEUTICS MARKET: RESEARCHAI
FIGURE 22. MRNA THERAPEUTICS MARKET: RESEARCHSTATISTICS
FIGURE 23. MRNA THERAPEUTICS MARKET: RESEARCHCONTACTS
FIGURE 24. MRNA THERAPEUTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. MRNA THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL MRNA THERAPEUTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL MRNA THERAPEUTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY LIPID NANOPARTICLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY POLYMER BASED, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY POLYMER BASED, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY VIRAL VECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY RARE DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL MRNA THERAPEUTICS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 36. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 37. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 38. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 39. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 40. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 41. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 42. AMERICAS MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 43. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 44. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 45. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 46. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 47. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 48. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 49. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 50. UNITED STATES MRNA THERAPEUTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 51. CANADA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 52. CANADA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 53. CANADA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 54. CANADA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 55. CANADA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 56. CANADA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 57. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 58. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 59. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 60. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 61. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 62. MEXICO MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 63. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 64. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 65. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 66. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 67. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 68. BRAZIL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 69. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 70. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 71. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 72. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 73. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 74. ARGENTINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 77. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 78. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 83. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 84. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 85. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 86. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 87. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 88. UNITED KINGDOM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 89. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 90. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 91. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 94. GERMANY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 95. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 96. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 97. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 98. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 99. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 100. FRANCE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 101. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 102. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 103. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 104. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 105. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 106. RUSSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 107. ITALY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 108. ITALY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 109. ITALY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. ITALY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. ITALY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 112. ITALY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 113. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 114. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 115. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 116. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 117. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 118. SPAIN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 119. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 120. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 121. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 122. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 123. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 124. UNITED ARAB EMIRATES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 126. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 127. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 130. SAUDI ARABIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 132. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 134. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 135. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 136. SOUTH AFRICA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 137. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 138. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 139. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 140. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 141. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 142. DENMARK MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 143. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 144. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 145. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 146. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 147. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 148. NETHERLANDS MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 149. QATAR MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 150. QATAR MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 151. QATAR MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 152. QATAR MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 153. QATAR MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 154. QATAR MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 155. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 156. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 157. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 158. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 159. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 160. FINLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 161. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 162. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 163. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 164. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 165. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 166. SWEDEN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 167. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 168. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 169. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 170. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 171. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 172. NIGERIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 173. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 174. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 175. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 178. EGYPT MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 179. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 180. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 181. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 182. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 183. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 184. TURKEY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 185. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 186. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 187. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 188. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 189. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 190. ISRAEL MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 191. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 192. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 193. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 194. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 195. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 196. NORWAY MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 197. POLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 198. POLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 199. POLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 200. POLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 201. POLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 202. POLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 203. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 204. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 205. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 206. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 207. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 208. SWITZERLAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 209. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 210. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 211. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 212. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 213. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 214. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 215. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 216. ASIA-PACIFIC MRNA THERAPEUTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 217. CHINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 218. CHINA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 219. CHINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 220. CHINA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 221. CHINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 222. CHINA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 223. INDIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 224. INDIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 225. INDIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. INDIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. INDIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 228. INDIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 229. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 230. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 231. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 232. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 233. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 234. JAPAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 235. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 236. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 237. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 238. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 239. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 240. AUSTRALIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 241. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 242. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 243. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 244. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 245. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 246. SOUTH KOREA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 247. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 248. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 249. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 250. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 251. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 252. INDONESIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 253. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 254. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 255. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 256. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 257. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 258. THAILAND MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 259. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 260. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 261. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 262. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 263. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 264. PHILIPPINES MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 265. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 266. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 267. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 268. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 269. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 270. MALAYSIA MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 271. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 272. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 273. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 276. SINGAPORE MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 277. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 278. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 279. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 280. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 281. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 282. VIETNAM MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 283. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2018-2024 (USD MILLION)
TABLE 284. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY TECHNOLOGY PLATFORM, 2025-2030 (USD MILLION)
TABLE 285. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2024 (USD MILLION)
TABLE 286. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY THERAPEUTIC APPLICATION, 2025-2030 (USD MILLION)
TABLE 287. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2018-2024 (USD MILLION)
TABLE 288. TAIWAN MRNA THERAPEUTICS MARKET SIZE, BY DELIVERY METHOD, 2025-2030 (USD MILLION)
TABLE 289. MRNA THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 290. MRNA THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this mRNA Therapeutics market report include:
  • Moderna, Inc.
  • BioNTech SE
  • CureVac N.V.
  • Sanofi S.A.
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Arcturus Therapeutics Holdings, Inc.
  • Providence Therapeutics Holdings Inc.
  • Ethris GmbH
  • eTheRNA immunotherapies NV

Table Information

Report AttributeDetails
No. of Pages195
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 52.59 Billion
Forecasted Market Value ( USD ) by 2030 $ 158.6 Billion
Compound Annual Growth Rate24.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

mRNA Therapeutics Contract Development & Manufacturing Organization Market Size, Share & Trends Analysis Report By Indication (Metabolic & Genetic Diseases), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 170 Pages
  • Global
From
mRNA Therapeutics - Global Strategic Business Report - Product Image

mRNA Therapeutics - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report - Product Image

mRNA Therapeutics Contract Development & Manufacturing Organization - Global Strategic Business Report

  • Report
  • 166 Pages
  • Global
From
mRNA Therapeutics Market Report 2025 - Product Image

mRNA Therapeutics Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Mrna Therapeutics Contract Development & Manufacturing Organization Market by Application, by Indication, by End-user, and by Region - Product Image

Mrna Therapeutics Contract Development & Manufacturing Organization Market by Application, by Indication, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From

About the mRNA Therapeutics Market

The mRNA Therapeutics market is a subset of the larger Genomics market, which focuses on the development of therapeutics based on messenger RNA (mRNA). mRNA is a type of genetic material that is used to produce proteins in cells. mRNA Therapeutics are designed to target specific diseases by delivering mRNA molecules to cells, which can then be used to produce proteins that can treat or prevent the disease. mRNA Therapeutics have the potential to revolutionize the way diseases are treated, as they can be used to target specific diseases without affecting other parts of the body. The mRNA Therapeutics market is still in its early stages, but is expected to grow rapidly in the coming years. Companies in the market are focused on developing mRNA-based therapeutics for a variety of diseases, including cancer, cardiovascular diseases, and neurological disorders. Some of the companies in the mRNA Therapeutics market include Moderna, CureVac, Arcturus Therapeutics, and BioNTech. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.